Found 6 matching trials
A Phase 1 Study of Givosiran (ALN-AS1) in Patients With Acute Intermittent Porphyria (AIP)
PHASE1The purpose of this study is to evaluate the safety and tolerability of giv...
Location
Clinical Trial Site
ELEVATE, a Registry of Patients With Acute Hepatic Porphyria (AHP)
N/AThis global patient registry is being conducted to characterize the natural...
Location
Clinical Trial Site
A Study to Evaluate Long-term Safety and Clinical Activity of Givosiran (ALN-AS1) in Patient With Acute Intermittent Porphyria (AIP)
PHASE1The purpose of this study is to determine the long-term safety, tolerabilit...
Location
Clinical Trial Site
Expanded Access Protocol of Givosiran for Patients With Acute Hepatic Porphyria
N/AThe purpose of this study is to provide expanded access of givosiran to pat...
Status
Approved For Marketing
Location
Multiple Locations
ENVISION: A Study to Evaluate the Efficacy and Safety of Givosiran (ALN-AS1) in Patients With Acute Hepatic Porphyrias (AHP)
PHASE3The purpose of this study is to evaluate the effect of subcutaneous givosir...
Location
Clinical Trial Site
A Study to Investigate the Interaction Between Givosiran and a 5-probe Drug Cocktail in Patients With Acute Intermittent Porphyria (AIP)
PHASE1The purpose of this study is to evaluate the effect of givosiran on the pha...
Location
Clinical Trial Site